APA

Ando M., Watanabe T., Sasaki Y., Ying D. F., Omuro Y., Katsumata N., Narabayashi M., Tokue Y., Fujii H., Igarashi T., Wakita H., Ohtsu T., Itoh K., Adachi I. & Taguchi T. (19980730). A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer. : British journal of cancer.

Chicago

Ando M, Watanabe T, Sasaki Y, Ying D F, Omuro Y, Katsumata N, Narabayashi M, Tokue Y, Fujii H, Igarashi T, Wakita H, Ohtsu T, Itoh K, Adachi I and Taguchi T. 19980730. A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer. : British journal of cancer.

Harvard

Ando M., Watanabe T., Sasaki Y., Ying D. F., Omuro Y., Katsumata N., Narabayashi M., Tokue Y., Fujii H., Igarashi T., Wakita H., Ohtsu T., Itoh K., Adachi I. and Taguchi T. (19980730). A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer. : British journal of cancer.

MLA

Ando M, Watanabe T, Sasaki Y, Ying D F, Omuro Y, Katsumata N, Narabayashi M, Tokue Y, Fujii H, Igarashi T, Wakita H, Ohtsu T, Itoh K, Adachi I and Taguchi T. A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer. : British journal of cancer. 19980730.